Join
Live feed
·
INSIDERFilingvia Quantisnow
Amgen Inc. logo

EVP, Research and Development Bradner James E. was granted 3,337 shares and covered exercise/tax liability with 407 shares, increasing direct ownership by 11% to 30,462 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AMGN· Amgen Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AMGN (Amgen Inc.) and more on Quantisnow.